NASDAQ : IRMD
IRADIMED CORPORATION — Key statistics
Healthcare · Medical Devices · United States
Last price 76.68 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 980.51M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 980.60M |
| Enterprise Value | 917.31M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Nov 13, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 12.79M |
| Shares Outstanding | 12.79M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 34.85% |
| Owned by Institutions (%) | 60.80% |
| Float | 8.33M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 41.01 |
| Forward PE | 35.27 |
| PS Ratio | 10.98 |
| Forward PS | n/a |
| PB Ratio | 9.21 |
| P/TBV Ratio | 9.52 |
| P/FCF Ratio | 37.52 |
| P/OCF Ratio | 36.12 |
| PEG Ratio | 2.94 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 38.25 |
| EV / Sales | 10.27 |
| EV / EBITDA | 30.06 |
| EV / EBIT | 31.78 |
| EV / FCF | 35.10 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.99 |
| Quick Ratio | 7.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 23.42% |
| Return on Assets (ROA) | 15.30% |
| Return on Invested Capital (ROIC) | 51.83% |
| Return on Capital Employed (ROCE) | 26.06% |
| Weighted Average Cost of Capital (WACC) | 9.44% |
| Revenue Per Employee | $538,193 |
| Profits Per Employee | $144,482 |
| Employee Count | 166 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 1.73 |
Taxes
| Measure | Value |
|---|
| Income Tax | 7.13M |
| Effective Tax Rate | 22.92% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -2.08% |
| 50-Day Moving Average | 85.66 |
| 200-Day Moving Average | 92.54 |
| Relative Strength Index (RSI) | 25.64 |
| Average Volume (20 Days) | 110,300 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 670,183 |
| Short Previous Month | 657,367 |
| Short % of Shares Out | 5.24% |
| Short % of Float | 8.05% |
| Short Ratio (days to cover) | 5.23 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 89.34M |
| Gross Profit | 67.46M |
| Operating Income | 28.86M |
| Pretax Income | 31.12M |
| Net Income | 23.98M |
| EBITDA | 30.52M |
| EBIT | 28.86M |
| Earnings Per Share (EPS) | $1.87 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 63.29M |
| Total Debt | n/a |
| Net Cash | 63.29M |
| Net Cash Per Share | $4.95 |
| Equity (Book Value) | 106.45M |
| Book Value Per Share | 8.32 |
| Working Capital | 82.48M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 27.15M |
| Capital Expenditures | -1.01M |
| Depreciation & Amortization | 1.66M |
| Net Borrowing | n/a |
| Free Cash Flow | 26.14M |
| FCF Per Share | $2.04 |
Margins
| Measure | Value |
|---|
| Gross Margin | 75.51% |
| Operating Margin | 32.30% |
| Pretax Margin | 34.83% |
| Profit Margin | 26.85% |
| EBITDA Margin | 34.16% |
| EBIT Margin | 32.30% |
| FCF Margin | 29.26% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.80 |
| Dividend Yield | 1.04% |
| Dividend Growth (YoY) | 17.65% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 42.79% |
| FCF Payout Ratio | 39.14% |
| Buyback Yield | -0.26% |
| Shareholder Yield | 0.79% |
| Earnings Yield | 2.44% |
| FCF Yield | 2.67% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $118.00 |
| Price Target Difference | 53.89% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 11.06% |
| EPS Growth Forecast (3Y) | 12.05% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 51.16 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |